Bill Few Associates Inc. lessened its holdings in shares of Procter & Gamble Company (The) (NYSE:PG – Free Report) by 0.7% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 32,361 shares of the company’s stock after selling 232 shares during the quarter. Procter & Gamble accounts for 1.5% of Bill Few Associates Inc.’s portfolio, making the stock its 14th largest position. Bill Few Associates Inc.’s holdings in Procter & Gamble were worth $5,156,000 as of its most recent SEC filing.
Other hedge funds have also recently bought and sold shares of the company. Nova Wealth Management Inc. acquired a new stake in Procter & Gamble during the 1st quarter valued at approximately $26,000. Signature Resources Capital Management LLC grew its position in shares of Procter & Gamble by 67.9% in the 2nd quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares in the last quarter. Quarry LP acquired a new position in shares of Procter & Gamble in the 1st quarter worth approximately $33,000. Mizuho Securities Co. Ltd. grew its position in shares of Procter & Gamble by 566.7% in the 1st quarter. Mizuho Securities Co. Ltd. now owns 200 shares of the company’s stock worth $34,000 after acquiring an additional 170 shares in the last quarter. Finally, RMG Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $37,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Trading Down 0.6%
NYSE:PG opened at $149.69 on Monday. Procter & Gamble Company has a 12-month low of $149.45 and a 12-month high of $180.43. The firm has a market capitalization of $350.34 billion, a P/E ratio of 22.99, a P/E/G ratio of 3.97 and a beta of 0.36. The company has a debt-to-equity ratio of 0.49, a current ratio of 0.70 and a quick ratio of 0.49. The business has a 50 day simple moving average of $155.24 and a 200 day simple moving average of $159.41.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on PG shares. Wells Fargo & Company decreased their target price on Procter & Gamble from $173.00 to $170.00 and set an “overweight” rating for the company in a research report on Thursday, September 25th. Barclays decreased their target price on Procter & Gamble from $164.00 to $153.00 and set an “equal weight” rating for the company in a research report on Wednesday, October 1st. UBS Group decreased their target price on Procter & Gamble from $180.00 to $176.00 and set a “buy” rating for the company in a research report on Wednesday. Weiss Ratings reiterated a “hold (c+)” rating on shares of Procter & Gamble in a research report on Wednesday, October 8th. Finally, BNP Paribas reiterated an “outperform” rating and issued a $177.00 target price on shares of Procter & Gamble in a research report on Friday, August 15th. Eleven analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat, Procter & Gamble has a consensus rating of “Moderate Buy” and an average price target of $172.21.
Get Our Latest Research Report on Procter & Gamble
Insider Activity
In other Procter & Gamble news, insider Balaji Purushothaman sold 490 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $74,592.70. Following the sale, the insider owned 12,616 shares of the company’s stock, valued at $1,920,533.68. The trade was a 3.74% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Shailesh Jejurikar sold 3,986 shares of Procter & Gamble stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the sale, the chief operating officer directly owned 46,899 shares in the company, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 149,763 shares of company stock worth $23,421,279 over the last ninety days. 0.20% of the stock is currently owned by company insiders.
About Procter & Gamble
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
See Also
- Five stocks we like better than Procter & Gamble
- ETF Screener: Uses and Step-by-Step Guide
- Microsoft 365 Premium Marks the Next Phase of AI Monetization
- 5 Top Rated Dividend Stocks to Consider
- Could Target’s Week of Discounts Come Full Circle for Investors?
- What is diluted earnings per share (Diluted EPS)?
- 3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.